Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Zilliz | 2022 | Series B | Undisclosed | Redwood City |
| XYZ Robotics | 2022 | Series B | Undisclosed | Allston |
| LTZ Therapeutics | 2026 | Venture - Series Unknown | $40.0M | San Francisco |
| Aureka Biotechnologies | 2026 | Series A | $23.4M | Laguna Hills |
| ReviR Therapeutics | 2026 | Corporate Round | Undisclosed | Brisbane |
| Dify.AI | 2026 | Seed | $30.0M | Sunnyvale |
| Hopewell Therapeutics | 2025 | Venture - Series Unknown | $2.5M | Woburn |
| Omi AI | 2025 | Pre-Seed | $2.0M | San Francisco |
| Haiper | 2023 | Seed | $13.8M | London |
| Share Creators | 2023 | Series A | $5.0M | Burlingame |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Zilliz | Series B | Undisclosed | Redwood City, United States |
| 2 | XYZ Robotics | Series B | Undisclosed | Allston, United States |
| 3 | LTZ Therapeutics | Venture - Series Unknown | $40.0M | San Francisco, United States |
| 4 | Aureka Biotechnologies | Series A | $23.4M | Laguna Hills, United States |
| 5 | ReviR Therapeutics | Corporate Round | Undisclosed | Brisbane, United States |
| 6 | Dify.AI | Seed | $30.0M | Sunnyvale, United States |
| 7 | Hopewell Therapeutics | Venture - Series Unknown | $2.5M | Woburn, United States |
| 8 | Omi AI | Pre-Seed | $2.0M | San Francisco, United States |
| 9 | Haiper | Seed | $13.8M | London, United Kingdom |
| 10 | Share Creators | Series A | $5.0M | Burlingame, United States |
The company behind the Milvus open-source vector database
XYZ Robotics develops AI-enabled robotic perception and manipulation technology for logistics and manufacturing automation.
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Dify is an open-source platform designed to build, deploy, and manage autonomous AI agents and workflows.
Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.
Haiper is building perceptual foundation models for video/3D content creation
Share Creators offers digital asset and project management tools to help game developers manage and store media assets.
Redesign Science is a computational chemistry company setting a new standard for early-stage, small molecule drug discovery.
Treelab simplifies sourcing so you can focus on building your brand and growing revenue
YouWare AI platform enable creators to turn ideas into living, interactive projects.
Agora.io enables developers to add HD interactive broadcast, voice, and video calls into mobile and web apps through SDK.
D-Robotics is a provider of robotic computing solutions.
HT Aero aspires to be the pioneer of urban air mobility (UAM) and is dedicated to producing safe and intelligent electric flying vehicles.
BOTINKIT is creating the first robot-based digital food ecosystem in the world.
QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
Wangli Technology is a digital therapy technology platform for mental illness.
StepFun is an AI technology company that develops large language models and multimodal AI systems to process and generate text.
Nature Select is a software company that develops AI memory models, multimodal interaction systems, and 3D interactive gameplay.
Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs.
Zenitar is a biomedical technology company engaged in innovative drug research and industrialization processes.
Noitom Robotics is an intelligent robot development company specializing in the sales, installation, and maintenance of industrial robots.
Allink Biotherapeutics is a biopharmaceutical company that develops multi-specific antibodies for oncology and immunology treatment.
5Y Capital has invested in 127 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
5Y Capital's top investment sectors include Artificial Intelligence (AI), Biotechnology, Health Care, Medical, Software. The firm invests across 47 different industry categories.
Among tracked funding rounds, StepFun received $718.1M in a Series B round. 5Y Capital's total known invested capital is $4.5B.
5Y Capital's average investment size is $52.1M across its portfolio of 127 companies.
Recent 5Y Capital portfolio additions include Zilliz, XYZ Robotics, LTZ Therapeutics, Aureka Biotechnologies, ReviR Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors